276 related articles for article (PubMed ID: 14694243)
21. Total polysaccharide of Yupingfeng protects against bleomycin-induced pulmonary fibrosis via inhibiting transforming growth factor-β1-mediated type I collagen abnormal deposition in rats.
Xu L; Li LC; Zhao P; Qi LW; Li P; Gao J; Fei GH
J Pharm Pharmacol; 2014 Dec; 66(12):1786-95. PubMed ID: 25209833
[TBL] [Abstract][Full Text] [Related]
22. Effects of candesartan cilexetil (TCV-116) and enalapril in 5/6 nephrectomized rats.
Noda M; Fukuda R; Matsuo T; Ohta M; Nagano H; Imura Y; Nishikawa K; Shibouta Y
Kidney Int Suppl; 1997 Dec; 63():S136-9. PubMed ID: 9407442
[TBL] [Abstract][Full Text] [Related]
23. Use of tetrandrine to differentiate between mechanisms involved in silica-versus bleomycin-induced fibrosis.
Ma JY; Barger MW; Hubbs AF; Castranova V; Weber SL; Ma JK
J Toxicol Environ Health A; 1999 Jun; 57(4):247-66. PubMed ID: 10406349
[TBL] [Abstract][Full Text] [Related]
24. Candesartan, an angiotensin II receptor antagonist, suppresses pancreatic inflammation and fibrosis in rats.
Yamada T; Kuno A; Masuda K; Ogawa K; Sogawa M; Nakamura S; Ando T; Sano H; Nakazawa T; Ohara H; Nomura T; Joh T; Itoh M
J Pharmacol Exp Ther; 2003 Oct; 307(1):17-23. PubMed ID: 12944495
[TBL] [Abstract][Full Text] [Related]
25. Effects of angiotensin-II receptor blocker candesartan cilexetil in rats with dilated cardiomyopathy.
Shirai K; Watanabe K; Ma M; Wahed MI; Inoue M; Saito Y; Suresh PS; Kashimura T; Tachikawa H; Kodama M; Aizawa Y
Mol Cell Biochem; 2005 Jan; 269(1-2):137-42. PubMed ID: 15786726
[TBL] [Abstract][Full Text] [Related]
26. Effects of angiotensin II AT1 receptor inhibition and exercise training on insulin action in rats on high-fat diet.
Wang Z; Koike T; Li P; Jiang H; Natsume Y; Mu L; Chen T; Oshida Y
Life Sci; 2012 Feb; 90(9-10):322-7. PubMed ID: 22210187
[TBL] [Abstract][Full Text] [Related]
27. AT1 receptor antagonist Candesartan in selected cirrhotic patients: effect on portal pressure and liver fibrosis markers.
Debernardi-Venon W; Martini S; Biasi F; Vizio B; Termine A; Poli G; Brunello F; Alessandria C; Bonardi R; Saracco G; Rizzetto M; Marzano A
J Hepatol; 2007 Jun; 46(6):1026-33. PubMed ID: 17336417
[TBL] [Abstract][Full Text] [Related]
28. Effects of AT1 receptor blockade on renal injury and mitogen-activated protein activity in Dahl salt-sensitive rats.
Nishiyama A; Yoshizumi M; Rahman M; Kobori H; Seth DM; Miyatake A; Zhang GX; Yao L; Hitomi H; Shokoji T; Kiyomoto H; Kimura S; Tamaki T; Kohno M; Abe Y
Kidney Int; 2004 Mar; 65(3):972-81. PubMed ID: 14871417
[TBL] [Abstract][Full Text] [Related]
29. Early lung injury contributes to lung fibrosis via AT1 receptor in rats.
Chen FP; Gong LK; Zhang L; Wang H; Qi XM; Wu XF; Xiao Y; Cai Y; Liu LL; Li XH; Ren J
Acta Pharmacol Sin; 2007 Feb; 28(2):227-37. PubMed ID: 17241526
[TBL] [Abstract][Full Text] [Related]
30. Transforming growth factor beta receptor endoglin is expressed in cardiac fibroblasts and modulates profibrogenic actions of angiotensin II.
Chen K; Mehta JL; Li D; Joseph L; Joseph J
Circ Res; 2004 Dec; 95(12):1167-73. PubMed ID: 15539634
[TBL] [Abstract][Full Text] [Related]
31. Protective roles of pulmonary rehabilitation mixture in experimental pulmonary fibrosis in vitro and in vivo.
Zhang L; Ji YX; Jiang WL; Lv CJ
Braz J Med Biol Res; 2015 Jun; 48(6):545-52. PubMed ID: 25992646
[TBL] [Abstract][Full Text] [Related]
32. Neuroprotection against retinal ischemia-reperfusion injury by blocking the angiotensin II type 1 receptor.
Fukuda K; Hirooka K; Mizote M; Nakamura T; Itano T; Shiraga F
Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3629-38. PubMed ID: 20164447
[TBL] [Abstract][Full Text] [Related]
33. Oxymatrine attenuates bleomycin-induced pulmonary fibrosis in mice via the inhibition of inducible nitric oxide synthase expression and the TGF-β/Smad signaling pathway.
Liu L; Lu W; Ma Z; Li Z
Int J Mol Med; 2012 May; 29(5):815-22. PubMed ID: 22367596
[TBL] [Abstract][Full Text] [Related]
34. Preventive Effects of Rhodiola rosea L. on Bleomycin-Induced Pulmonary Fibrosis in Rats.
Zhang K; Si XP; Huang J; Han J; Liang X; Xu XB; Wang YT; Li GY; Wang HY; Wang JH
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27271612
[TBL] [Abstract][Full Text] [Related]
35. Renal protective effect of candesartan cilexetil in spontaneously hypercholesterolemic rats.
Matsuo T; Ishikawa E; Ohta M; Shibouta Y; Ishimura Y; Imura Y; Sugiyama Y
Jpn J Pharmacol; 2002 Mar; 88(3):300-6. PubMed ID: 11949885
[TBL] [Abstract][Full Text] [Related]
36. [Perindopril and losartan attenuate bleomycin A5-induced pulmonary fibrosis in rats].
Meng Y; Meng Y; Li X; Cai SX; Tong WC; Cheng YX
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):919-24. PubMed ID: 18583228
[TBL] [Abstract][Full Text] [Related]
37. Effect of Angiotensin II Type 1 receptor blocker on cardiac angiotensin-converting enzyme and chymase-like activities, and cardiac fibrosis in cardiomyopathic hamsters.
Shimizu M; Tanaka R; Uchida M; Orito K; Shimamura S; Yamane Y
J Vet Med Sci; 2006 Mar; 68(3):227-33. PubMed ID: 16598165
[TBL] [Abstract][Full Text] [Related]
38. Candesartan cilexetil protects from cardiac myosin induced cardiotoxicity via reduction of endoplasmic reticulum stress and apoptosis in rats: involvement of ACE2-Ang (1-7)-mas axis.
Arumugam S; Thandavarayan RA; Palaniyandi SS; Giridharan VV; Arozal W; Sari FR; Soetikno V; Harima M; Suzuki K; Kodama M; Watanabe K
Toxicology; 2012 Jan; 291(1-3):139-45. PubMed ID: 22120037
[TBL] [Abstract][Full Text] [Related]
39. [Effects of antisense oligonucleotide to nuclear factor-kappaB on the development of bleomycin-induced pulmonary fibrosis and IL-4 expression therein: experiment with mice].
Zhang XY; Zhou Y; Liu WQ; Zhao L; Li SQ
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):195-9. PubMed ID: 17425852
[TBL] [Abstract][Full Text] [Related]
40. Protective effect of rutin against bleomycin induced lung fibrosis: Involvement of TGF-β1/α-SMA/Col I and III pathway.
Bai L; Li A; Gong C; Ning X; Wang Z
Biofactors; 2020 Jul; 46(4):637-644. PubMed ID: 32233122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
